O. Nishio

Molecular Cancer apeutics cular Medicine in Practice se I Safety , Pharmacokinetic , and Biomarker Study of F 1120 , an Oral Triple Tyrosine Kinase Inhibitor in Ther ients with Advanced Solid Tumors

R. Kaiser, T. Satoh, A. Tsuya, 2010 .

I Safety , Pharmacokinetic , and Biomarker Study of F 1120 , an Oral Triple Tyrosine Kinase Inhibitor in Ther ients with Advanced Solid Tumors

R. Kaiser, T. Satoh, A. Tsuya, 2010 .

Exposure to gp120 of HIV‐1 Induces an Increased Release of Arachidonic Acid in Rat Primary Neuronal Cell Culture Followed by NMDA Receptor‐mediated Neurotoxicity

H. Ushijima, W. Müller, R. Klöcking, 1995, The European journal of neuroscience.

Carcinogenicities of quinoline derivatives in F344 rats.

S. Fukushima, T. Shirai, N. Ito, 1981, Cancer letters.